FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2900808567> ?p ?o ?g. }

• W2900808567 endingPage "7621" @default.
• W2900808567 startingPage "7607" @default.
• W2900808567 abstract "Fabricating polydopamine-coated MoSe2-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy Song Chai,1,* Shifeng Kan,1,* Ran Sun,1 Ruijuan Zhou,1 Yi Sun,2 Wenhua Chen,1 Bo Yu1,3 1Department of Rehabilitation, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, China; 2Department of Rehabilitation, Shanghai Sunshine Rehabilitation Center, Yangzhi Affiliated Rehabilitation Hospital of Tongji University, Shanghai 201209, China; 3Department of Rehabilitation Therapy, School of International Medical Technology, Shanghai Sanda University, Shanghai 201209, China *These authors contributed equally to this work Background: Integration of several types of therapeutic agents into one nanoplatform to enhance treatment efficacy is being more widely used for cancer therapy. Methods: Herein, a biocompatible polydopamine (PDA)-coated MoSe2-wrapped doxorubicin (DOX)-loaded hollow mesoporous silica nanoparticles (HMSNs) nanoplatform (PM@HMSNs-DOX) was fabricated for dual-sensitive drug release and chemo-photothermal therapy for enhancing the therapeutic effects on breast cancer. The HMSNs were obtained by a “structural difference-based selective etching” strategy and served as the drug carrier, exhibiting a high DOX loading capacity of 427 mg/g HMSNs-NH2, and then wrapped with PDA-coated MoSe2 layer to form PM@HMSNs-DOX. Various techniques proved the successful fabrication of the nanocomposites. Results: The formed PM@HMSNs-DOX nanocomposites exhibited good biocompatibility, good stability, and super-additive photothermal conversion efficiency due to the cooperation of MoSe2 and PDA. Simultaneously, the pH/near-infrared-responsive drug release profile was observed, which could enhance the synergistic therapeutic anticancer effect. The antitumor effects of PM@HMSNs-DOX were evaluated both in vitro and in vivo, demonstrating that the synergistic therapeutic efficacy was significantly superior to any monotherapy. Also, in vivo pharmacokinetics studies showed that PM@HMSNs-DOX had a much longer circulation time than free DOX. In addition, in vitro and in vivo toxicity studies certified that PM@HMSNs are suitable as biocompatible agents. Conclusion: Our nanoplatform loaded with DOX displays pH/near-infrared-induced chemotherapy and excellent photothermal therapy, which hold great potential for cancer treatment. Keywords: hollow mesoporous silica nanoparticles, MoSe2, polydopamine, chemo-photothermal therapy" @default.
• W2900808567 created "2018-11-29" @default.
• W2900808567 creator A5023213159 @default.
• W2900808567 creator A5041384316 @default.
• W2900808567 creator A5055884962 @default.
• W2900808567 creator A5073491424 @default.
• W2900808567 creator A5078351765 @default.
• W2900808567 creator A5081958822 @default.
• W2900808567 creator A5090934539 @default.
• W2900808567 date "2018-11-01" @default.
• W2900808567 modified "2023-10-05" @default.
• W2900808567 title "Fabricating polydopamine-coated MoSe₂-wrapped hollow mesoporous silica nanoplatform for controlled drug release and chemo-photothermal therapy" @default.
• W2900808567 cites W1801425213 @default.
• W2900808567 cites W1996921023 @default.
• W2900808567 cites W2012154711 @default.
• W2900808567 cites W2027237872 @default.
• W2900808567 cites W2053890812 @default.
• W2900808567 cites W2082176036 @default.
• W2900808567 cites W2094071195 @default.
• W2900808567 cites W2110971075 @default.
• W2900808567 cites W2123029732 @default.
• W2900808567 cites W2124998760 @default.
• W2900808567 cites W2156030525 @default.
• W2900808567 cites W2167577902 @default.
• W2900808567 cites W2217123187 @default.
• W2900808567 cites W2324080174 @default.
• W2900808567 cites W2329969567 @default.
• W2900808567 cites W2410597493 @default.
• W2900808567 cites W2413193118 @default.
• W2900808567 cites W2415242526 @default.
• W2900808567 cites W2428882792 @default.
• W2900808567 cites W2463359016 @default.
• W2900808567 cites W2519690167 @default.
• W2900808567 cites W2527571759 @default.
• W2900808567 cites W2541936781 @default.
• W2900808567 cites W2554773181 @default.
• W2900808567 cites W2563570451 @default.
• W2900808567 cites W2566222736 @default.
• W2900808567 cites W2567335715 @default.
• W2900808567 cites W2589767790 @default.
• W2900808567 cites W2613959205 @default.
• W2900808567 cites W2615993918 @default.
• W2900808567 cites W2731448863 @default.
• W2900808567 cites W2745883884 @default.
• W2900808567 cites W2748265106 @default.
• W2900808567 cites W2753338108 @default.
• W2900808567 cites W2767074976 @default.
• W2900808567 cites W2767234044 @default.
• W2900808567 cites W2778172855 @default.
• W2900808567 cites W2791440760 @default.
• W2900808567 cites W2800971234 @default.
• W2900808567 cites W2915478882 @default.
• W2900808567 doi "https://doi.org/10.2147/ijn.s181681" @default.
• W2900808567 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6248227" @default.
• W2900808567 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30510420" @default.
• W2900808567 hasPublicationYear "2018" @default.
• W2900808567 type Work @default.
• W2900808567 sameAs 2900808567 @default.
• W2900808567 citedByCount "22" @default.
• W2900808567 countsByYear W29008085672019 @default.
• W2900808567 countsByYear W29008085672020 @default.
• W2900808567 countsByYear W29008085672021 @default.
• W2900808567 countsByYear W29008085672022 @default.
• W2900808567 countsByYear W29008085672023 @default.
• W2900808567 crossrefType "journal-article" @default.
• W2900808567 hasAuthorship W2900808567A5023213159 @default.
• W2900808567 hasAuthorship W2900808567A5041384316 @default.
• W2900808567 hasAuthorship W2900808567A5055884962 @default.
• W2900808567 hasAuthorship W2900808567A5073491424 @default.
• W2900808567 hasAuthorship W2900808567A5078351765 @default.
• W2900808567 hasAuthorship W2900808567A5081958822 @default.
• W2900808567 hasAuthorship W2900808567A5090934539 @default.
• W2900808567 hasBestOaLocation W29008085671 @default.
• W2900808567 hasConcept C136229726 @default.
• W2900808567 hasConcept C141071460 @default.
• W2900808567 hasConcept C161790260 @default.
• W2900808567 hasConcept C171250308 @default.
• W2900808567 hasConcept C178790620 @default.
• W2900808567 hasConcept C182606246 @default.
• W2900808567 hasConcept C185592680 @default.
• W2900808567 hasConcept C191897082 @default.
• W2900808567 hasConcept C192562407 @default.
• W2900808567 hasConcept C2776694085 @default.
• W2900808567 hasConcept C2777230088 @default.
• W2900808567 hasConcept C2777496208 @default.
• W2900808567 hasConcept C2777742735 @default.
• W2900808567 hasConcept C2781303535 @default.
• W2900808567 hasConcept C71924100 @default.
• W2900808567 hasConcept C82776694 @default.
• W2900808567 hasConceptScore W2900808567C136229726 @default.
• W2900808567 hasConceptScore W2900808567C141071460 @default.
• W2900808567 hasConceptScore W2900808567C161790260 @default.
• W2900808567 hasConceptScore W2900808567C171250308 @default.
• W2900808567 hasConceptScore W2900808567C178790620 @default.
• W2900808567 hasConceptScore W2900808567C182606246 @default.
• W2900808567 hasConceptScore W2900808567C185592680 @default.
• W2900808567 hasConceptScore W2900808567C191897082 @default.
• W2900808567 hasConceptScore W2900808567C192562407 @default.

• next